#USA #Washington #Healthcare Innovation #CheckMySpot #skin cancer detection

CheckMySpot® Recognized for Transforming Skin Cancer Detection

On November 11, 2025, during the prestigious National Alliance of Healthcare Purchaser Coalitions Annual Forum, CheckMySpot® received commendations for its innovative approach to early skin cancer detection. This event brought together industry leaders dedicated to revolutionizing employer-sponsored healthcare. By spotlighting advancements that yield tangible benefits and improve patient outcomes, this forum serves as a pivotal platform for healthcare transformation.

The Impact of CheckMySpot®

CheckMySpot® is a Direct Access Platform™ that allows users to engage in proactive skin health management. At the core of its operation, the platform enables employees to take two smartphone photos of potentially concerning skin lesions. Within 24 hours, users receive an assessment from a certified dermatologist. The results demonstrate that over 80% of submitted cases do not require further medical intervention. Higher-risk cases are expedited to dermatology specialists for immediate assessment. This streamlined process significantly reduces wait times, transforming an often delayed and cumbersome experience into a rapid, efficient health service.

Dr. Joseph Webb, one of the co-founders and a board-certified Mohs surgeon, highlighted the alarming statistics surrounding skin cancer in the U.S. He pointed out that nearly one in five Americans will develop some form of skin cancer in their lifetime, and tragically, two lives are lost every hour due to complications from the disease. He also noted that early detection can be treated affordably, often for under $1,000, while late detection can incur exorbitant costs exceeding $750,000.

Benefits for Employers and Employees

The benefits of the CheckMySpot® platform extend beyond individual patients to employers and healthcare providers. Specifically, the tool has been validated to reduce annual claims spending by over 7%, minimizing liability associated with catastrophic claims and ensuring smoother operations through better workforce management. This translates to lower associated costs tied to employee absenteeism and presenteeism, which saw a staggering impact of $3.3 billion annually in productivity losses for employers across the nation.

For patients, the advantages include rapid access to board-certified dermatology assessments without the need to travel or take time off work. This not only brings peace of mind but also facilitates earlier treatments that are usually more effective and less financially burdensome.

Healthcare providers benefit from improved care coordination via optimized referral processes that ensure patients receive timely and appropriate treatment, thus enhancing clinical efficiency and optimizing case management.

Key Statistics Highlighted

Some essential statistics shared during the forum include:

• - 1 in 5 Americans will likely face skin cancer during their lifetime.
• - $9 billion is spent annually on skin cancer treatments in the U.S.
• - Productivity losses due to missed work and related disruptions amount to $3.3 billion.
• - Utilizing CheckMySpot® can significantly decrease risk for employers while improving employee health outcomes.

Looking Ahead: Commitment to Accessible Healthcare

CheckMySpot®'s recognition during the Innovator Showcase underscores the platform's commitment to enhancing the quality and accessibility of dermatological care. With its model, the company aims to bridge gaps in early detection, alleviate the burdens of delayed care in employer populations, and promote overall better health outcomes for all.

Dr. Webb expressed gratitude for the accolade, stating, "This recognition highlights our dedication to ensuring that all employees have prompt access to high-quality dermatologic care. It is possible to enhance patient survival rates through timely intervention, optimizing surgical results and lowering total healthcare costs."

In conclusion, CheckMySpot® stands at the forefront of the healthcare innovation wave, offering genuine hope and tangible solutions for early skin cancer detection while bringing stakeholders across the healthcare continuum together for better patient outcomes.